Taiwan may enter clinical trials for COVID-19 vaccine by year-end: CECC

Five research facilities and biotechnology companies in Taiwan are currently developing vaccines for the COVID-19 coronavirus, most of which are expected to enter clinical trials by the end of this year, the Central Epidemic Command Center (CECC) said Wednesday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)